In PD, in vitro studies have shown that MPP+, a metabolite of the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), can induce astrocytes to release IL-33 [98]. This evidence concerns the gene IL33 and Parkinson disease.